NBTX - CIK 0001760854
Nanobiotix S.A. trades as NBTX and has a market capitalization of $1.68 B, making it the #2238 largest US-listed company by market value. This page tracks Nanobiotix S.A. through 295 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-26 |
| 6-K | - | 2026-05-26 |
| 6-K | - | 2026-05-22 |
| Free writing prospectus | FWP | 2026-05-22 |
| Prospectus supplement | 424B5 | 2026-05-22 |
| 6-K | - | 2026-05-21 |
| 6-K | - | 2026-05-21 |
| 6-K | - | 2026-05-21 |
Voting Rights and Shares Capital of the Company | Nanobiotix
Nanobiotix Joins the Euronext Tech Leaders Index | Nanobiotix
Nanobiotix Provides First Quarter 2026 Operational and Financial Update | Nanobiotix
NANOBIOTIX Announces Closing of Global Offering | Nanobiotix
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million | Nanobiotix
The largest companies sharing Nanobiotix S.A.'s SEC industry classification (pharmaceutical preparations).
Nanobiotix S.A. (NBTX) has a market capitalization of $1.68 B as of 2026-06-11, ranking #2238 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.